| Source of record | UK Co-ordinating Committee on Cancer Research (UKCCCR) |
| ISRCTN | ISRCTN71826974 |
| Serial number at source | RADIATION |
| Title of trial | BNLI Randomised trial of Radiation dose in Non-Hodgkin's Lymphoma |
| Disease or condition | Lymphoma (non-Hodgkin's) |
| Current status of trial | Open |
| Objectives | Primary endpoint is local control. Secondary endpoints are local morbidity (skin reactions, mucositis, bone marrow depression, gastrointestinal upset for infradiaphragmatic field, dysphagia for supradiaphragmatic fields). |
| Eligibility criteria | 1. Any patient receiving local RT where the aim of the treatment is local control of that lymphoma, whether as radical treatment of Stage I disease, consolidation therapy after chemotherapy or palliation.
2. Histological diagnosis of NHL
3. Aged 18 years or over
4. Able to give informed consent |
| Sample size | Current accrual: 325 |
| Randomised interventions | Standard radiotherapy versus low dose radiotherapy |
| Contact details | UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
LONDON NW1 2DA
Tel: +44 (0) 20 7670 4723
Fax: +44 (0) 20 7670 4818
|
| Further information | Further information about this trial may be obtained from UKCCCR Register's own website, which contains full trial reports. |
| General information | Please visit the UKCCCR Register website for further general information. |
| Date live in mRCT | 01 April 2007 |
